norbuprenorphine has been researched along with Sensitivity and Specificity in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Cohier, C; Fontova, A; Mégarbane, B; Roussel, O; Salle, S | 1 |
| Kharasch, ED; Regina, KJ | 1 |
| Belsey, SL; Couchman, L; Flanagan, RJ | 1 |
| Alegakis, A; Belivanis, S; Kovatsi, L; Liesivuori, J; Mantsi, M; Tsatsakis, AM; Tzatzarakis, MN; Vakonaki, E | 1 |
| Brown, S; Carmical, J; Kyle, AR; Pryor, J; Shah, D | 1 |
| Heidbreder, C; Li, X; Liu, Y; Nasser, AF; Xu, A | 1 |
| Concheiro-Guisan, M; Huestis, MA; Kacinko, SL; Shakleya, DM | 1 |
| Concheiro, M; Huestis, MA; Johnson, RE; Jones, H; Shakleya, DM | 1 |
| Cervellin, G; Lippi, G; Mercadanti, M; Romero, A | 1 |
| Josefsson, M; Kronstrand, R; Seldén, TG | 1 |
| Lofwall, MR; Rodriguez-Rosas, ME; Siluk, D; Strain, EC; Wainer, IW | 1 |
| Huestis, MA; Kacinko, SL; Shakleya, DM | 1 |
| Christophersen, AS; Hegstad, S; Khiabani, HZ | 1 |
| Kintz, P; Mangin, P; Tracqui, A | 1 |
| Kazlauskas, R; Lisi, AM; Trout, GJ | 1 |
| Cowan, A; Gopal, S; Tzeng, TB | 1 |
1 trial(s) available for norbuprenorphine and Sensitivity and Specificity
| Article | Year |
|---|---|
Simultaneous determination of buprenorphine, norbuprenorphine and the enantiomers of methadone and its metabolite (EDDP) in human plasma by liquid chromatography/mass spectrometry.
Topics: Buprenorphine; Calibration; Humans; Mass Spectrometry; Methadone; Reference Standards; Reproducibility of Results; Sensitivity and Specificity | 2007 |
15 other study(ies) available for norbuprenorphine and Sensitivity and Specificity
| Article | Year |
|---|---|
Determination of buprenorphine, naloxone and phase I and phase II metabolites in rat whole blood by LC-MS/MS.
Topics: Animals; Biosensing Techniques; Blood Specimen Collection; Buprenorphine; Calibration; Chromatography, High Pressure Liquid; Glucuronides; Limit of Detection; Male; Metabolome; Metabolomics; Naloxone; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Solvents; Tandem Mass Spectrometry | 2020 |
High-sensitivity analysis of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in plasma and urine by liquid chromatography-mass spectrometry.
Topics: Buprenorphine; Chromatography, Liquid; Drug Stability; Humans; Least-Squares Analysis; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Microextraction; Tandem Mass Spectrometry | 2013 |
Buprenorphine detection in urine using liquid chromatography-high-resolution mass spectrometry: comparison with cloned enzyme donor immunoassay (ThermoFisher) and homogeneous enzyme immunoassay (immunalysis).
Topics: Analgesics, Opioid; Buprenorphine; Calibration; Chromatography, Liquid; Humans; Immunoenzyme Techniques; Narcotic Antagonists; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Substance Abuse Detection | 2014 |
Determination of buprenorphine, norbuprenorphine and naloxone in fingernail clippings and urine of patients under opioid substitution therapy.
Topics: Adult; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Chromatography, Liquid; Female; Heroin Dependence; Humans; Male; Mass Spectrometry; Nails; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction | 2015 |
UHPLC-MS/MS quantification of buprenorphine, norbuprenorphine, methadone, and glucuronide conjugates in umbilical cord plasma.
Topics: Blood Chemical Analysis; Blood Specimen Collection; Buprenorphine; Chromatography, High Pressure Liquid; Female; Fetal Blood; Glucuronides; Humans; Infant, Newborn; Methadone; Phospholipids; Pregnancy; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry | 2015 |
Simultaneous determination of buprenorphine, norbuprenorphine and naloxone in human plasma by liquid chromatography/tandem mass spectrometry.
Topics: Buprenorphine; Chromatography, Liquid; Humans; Naloxone; Plasma; Sensitivity and Specificity; Tandem Mass Spectrometry | 2016 |
Development and validation of a liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of buprenorphine, norbuprenorphine, and metabolites in human urine.
Topics: Buprenorphine; Chromatography, Liquid; Humans; Narcotic Antagonists; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Temperature | 2008 |
Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women.
Topics: Buprenorphine; Chromatography, Liquid; Female; Fetal Blood; Glucuronides; Humans; Linear Models; Narcotic Antagonists; Opioid-Related Disorders; Pregnancy; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2010 |
Unusual false-positive case of urinary screening for buprenorphine.
Topics: Buprenorphine; Chromatography, High Pressure Liquid; Equipment Failure Analysis; False Positive Reactions; Humans; Immunoassay; Narcotics; Sensitivity and Specificity; Substance Abuse Detection | 2011 |
Analysis of buprenorphine, norbuprenorphine, and their glucuronides in urine by liquid chromatography-mass spectrometry.
Topics: Buprenorphine; Chromatography, Liquid; Glucuronides; Humans; Reference Standards; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Substance Abuse Detection | 2003 |
Validation and application of a method for the determination of buprenorphine, norbuprenorphine, and their glucuronide conjugates in human meconium.
Topics: Buprenorphine; Calibration; Chromatography, Liquid; Female; Glucuronides; Humans; Infant; Meconium; Mothers; Opioid-Related Disorders; Pregnancy; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2008 |
[Determination of buprenorphine in urine].
Topics: Buprenorphine; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Glucuronides; Humans; Immunoassay; Mass Spectrometry; Narcotic Antagonists; Narcotics; Sensitivity and Specificity | 2008 |
HPLC/MS determination of buprenorphine and norbuprenorphine in biological fluids and hair samples.
Topics: Adult; Analgesics, Opioid; Body Fluids; Buprenorphine; Chromatography, High Pressure Liquid; Forensic Medicine; Gas Chromatography-Mass Spectrometry; Hair; Humans; Male; Sensitivity and Specificity | 1997 |
Gas chromatographic-mass spectrometric quantitation of urinary buprenorphine and norbuprenorphine after derivatization by direct extractive alkylation.
Topics: Analgesics, Opioid; Buprenorphine; Gas Chromatography-Mass Spectrometry; Glucuronidase; Humans; Hydrolysis; Methylation; Sensitivity and Specificity | 1997 |
Development and validation of a sensitive analytical method for the simultaneous determination of buprenorphine and norbuprenorphine in human plasma.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Calibration; Gas Chromatography-Mass Spectrometry; Humans; Molecular Structure; Reproducibility of Results; Sensitivity and Specificity | 2001 |